UroGen Pharma Ltd. - Ordinary Shares (URGN): Price and Financial Metrics

UroGen Pharma Ltd. - Ordinary Shares (URGN): $10.56

0.21 (-1.95%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add URGN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#121 of 337

in industry

URGN Price/Volume Stats

Current price $10.56 52-week high $20.70
Prev. close $10.77 52-week low $9.78
Day low $10.54 Volume 206,500
Day high $11.09 Avg. volume 349,832
50-day MA $10.91 Dividend yield N/A
200-day MA $13.18 Market Cap 247.67M

URGN Stock Price Chart Interactive Chart >


UroGen Pharma Ltd. - Ordinary Shares (URGN) Company Bio


UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing therapies for urological pathologies. The company is developing its product candidates as chemoablation agents, which are designed to remove tumors by non-surgical means, to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial carcinoma, and low-grade bladder cancer. The company was founded in 2004 and is based in Raanana, Israel.


URGN Latest News Stream


Event/Time News Detail
Loading, please wait...

URGN Latest Social Stream


Loading social stream, please wait...

View Full URGN Social Stream

URGN Price Returns

1-mo N/A
3-mo -8.57%
6-mo -25.42%
1-year -45.11%
3-year 71.99%
5-year -65.13%
YTD -0.85%
2024 -29.00%
2023 69.11%
2022 -6.73%
2021 -47.23%
2020 -46.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!